Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R G Dale

Showing results (81-90 of 89) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 89 results.
Acta Oncologica (Stockholm, Sweden)|August 30, 2006
Plasma TGFbeta1 during pelvic radiotherapy for gynaecological malignancyR Coker, S Kiani-Alikhan, A Stewart, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|January 31, 2003
Practical methods for compensating for missed treatment days in radiotherapy, with particular reference to head and neck schedulesR G Dale, J H Hendry, B Jones, et al.
The British Journal of Radiology|January 27, 2011
Pulsed brachytherapy: a modelled consideration of repair parameter uncertainties and their influence on treatment duration extension and daytime-only "block-schemes"T S A Underwood, R G Dale, A M Bidmead, et al.
British Journal of Cancer|November 1, 1988
Repeated antitumour antibody therapy in man with suppression of the host response by cyclosporin AJ A Ledermann, R H Begent, K D Bagshawe, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 1, 1996
Active minimisation of radiation scatter during breast radiotherapy: management implications for young patients with good-prognosis primary neoplasmsR J Epstein, S A Kelly, M Cook, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|January 1, 1996
A modelled comparison of the effects of using different ways to compensate for missed treatment days in radiotherapyJ H Hendry, S M Bentzen, R G Dale, et al.
British Journal of Cancer|September 1, 1989
Antibody distribution and dosimetry in patients receiving radiolabelled antibody therapy for colorectal cancerR H Begent, J A Ledermann, A J Green, et al.
NCI Monographs : a Publication of the National Cancer Institute|January 1, 1987
Use of second antibody in radioimmunotherapyR H Begent, K D Bagshawe, R B Pedley, et al.
Plos Neglected Tropical Diseases|January 14, 2014
Cofactor-independent phosphoglycerate mutase from nematodes has limited druggability, as revealed by two high-throughput screensGregory J Crowther, Michael L Booker, Min He, et al.
Pageof 9

Showing results (81-90 of 89) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 89 results.
Acta Oncologica (Stockholm, Sweden)|August 30, 2006
Plasma TGFbeta1 during pelvic radiotherapy for gynaecological malignancyR Coker, S Kiani-Alikhan, A Stewart, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|January 31, 2003
Practical methods for compensating for missed treatment days in radiotherapy, with particular reference to head and neck schedulesR G Dale, J H Hendry, B Jones, et al.
The British Journal of Radiology|January 27, 2011
Pulsed brachytherapy: a modelled consideration of repair parameter uncertainties and their influence on treatment duration extension and daytime-only "block-schemes"T S A Underwood, R G Dale, A M Bidmead, et al.
British Journal of Cancer|November 1, 1988
Repeated antitumour antibody therapy in man with suppression of the host response by cyclosporin AJ A Ledermann, R H Begent, K D Bagshawe, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 1, 1996
Active minimisation of radiation scatter during breast radiotherapy: management implications for young patients with good-prognosis primary neoplasmsR J Epstein, S A Kelly, M Cook, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|January 1, 1996
A modelled comparison of the effects of using different ways to compensate for missed treatment days in radiotherapyJ H Hendry, S M Bentzen, R G Dale, et al.
British Journal of Cancer|September 1, 1989
Antibody distribution and dosimetry in patients receiving radiolabelled antibody therapy for colorectal cancerR H Begent, J A Ledermann, A J Green, et al.
NCI Monographs : a Publication of the National Cancer Institute|January 1, 1987
Use of second antibody in radioimmunotherapyR H Begent, K D Bagshawe, R B Pedley, et al.
Plos Neglected Tropical Diseases|January 14, 2014
Cofactor-independent phosphoglycerate mutase from nematodes has limited druggability, as revealed by two high-throughput screensGregory J Crowther, Michael L Booker, Min He, et al.
Pageof 9